Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Link opens in a new tab
Search content at Aston Research Explorer
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Insulin icodec: evolution or revolution in diabetes therapy?
Srikanth Bellary
*
, Anthony H. Barnett
*
Corresponding author for this work
School of Biosciences
Aston India Centre for Applied Research
Biosciences Research Group (BRG)
College of Health and Life Sciences
Aston Research Centre for Health in Ageing
Aston University
Department of Diabetes and Endocrinology
Research output
:
Contribution to journal
›
Letter, comment/opinion or interview
›
peer-review
2
Link opens in a new tab
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Insulin icodec: evolution or revolution in diabetes therapy?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Insulin
100%
Diabetes Therapy
100%
Insulin Icodec
100%
Glycemic Control
50%
Treatment Satisfaction
50%
Medical Sciences
25%
Low Affinity
25%
Weight Gain
25%
Ultra-long
25%
Zinc
25%
Hypoglycemia
25%
Insulin Dose
25%
Lifesaving
25%
Research-led
25%
Pharmacodynamics
25%
Human Serum Albumin
25%
Human Insulin
25%
Protamine
25%
Insulin Administration
25%
Normal Physiology
25%
Once-weekly Administration
25%
Health Preserving
25%
Treatment Quality
25%
Long-acting Formulation
25%
Human Insulin Receptor
25%
Reversible Binding
25%
Quality of Life Satisfaction
25%
Analogue Insulin
25%
Medicine and Dentistry
Diabetes
100%
Glycemic Control
100%
Receptor
50%
Quality of Life
50%
Hypoglycemia
50%
Pharmacodynamics
50%
Human Insulin
50%
Recombinant Human Insulin
50%
Medical Science
50%
Protamine
50%
Ultralente
50%
Human Serum Albumin
50%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Analog
100%
Recombinant Human Insulin
100%
Human Insulin
100%
Receptor
50%
Hypoglycemia
50%
Pharmacodynamics
50%
Human Serum Albumin
50%
Protamine
50%
Insulin Zinc Suspension
50%
Immunology and Microbiology
Insulin
100%
Glycemic Control
22%
Serum (Blood)
11%
Insulin Receptor
11%
Pharmacodynamics
11%
Albumin
11%
Protamine
11%